New Approaches to the Treatment of Leukemia

1. Front Matter

   Pages i-vii

   PDF

2. Introduction

   • Emil J. Freireich, A. M. Marmont, E. A. McCulloch, J. K. H. Rees, P. Reizenstein

   Pages 1-3

3. Chemotherapy of the Leukaemias

   • John Kempton Harold Rees

   Pages 5-77

4. The Use of Biological Response Modifiers in Acute Myeloid Leukaemia

   • Peter Reizenstein

   Pages 79-86

5. Biological Characteristics of Acute Myeloblastic Leukaemia Contributing to Management Strategy

   • E. A. McCulloch

   Pages 87-116

6. Bone Marrow Transplantation

   • Alberto M. Marmont

   Pages 117-171

7. The Impact of Cytogenetics and Molecular Genetics on Diagnosis and Treatment

   • Emil J. Freireich

   Pages 173-186

8. Recent Advances in Chemotherapy for Certain Leukaemias

   • Peter H. Wiernik

   Pages 187-193

9. Back Matter

   Pages 195-196

   PDF

The European School of Oncology came into existence to respond to a need for informa­ tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Universi­ ties to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice.

• bone marrow
• chemotherapy
• cytogenetics
• genetics
• immunotherapy
• leukemia
• molecular genetics
• transplantation

• M. D. Anderson Cancer Center, The University of Texas, Houston, USA

  Emil J. Freireich

Policies and ethics